SimonMed Launches Ultrasound+ AI Program for Enhanced Breast and Thyroid Cancer Detection

SimonMed Imaging, one of the largest outpatient medical imaging providers and radiology practices in the United States, has launched Ultrasound+, an AI-powered ultrasound program designed to improve breast and thyroid cancer detection. The initiative is driven by Koios DS, an FDA-cleared artificial intelligence software that uses advanced algorithms trained on millions of data points to analyze ultrasound images in real time. Acting as a second read for radiologists, the technology detects subtle patterns associated with cancer that may not be visible to the human eye, supporting earlier and more accurate diagnoses.

Through a partnership with Koios Medical, SimonMed has implemented this AI technology system-wide across all locations that offer ultrasound exams. Koios DS Breast, the only FDA-cleared AI cancer diagnosis software for breast ultrasound images, functions as an on-demand expert opinion by classifying suspicious lesions and aligning them to BI-RADS® categories. The integration of this tool marks a major step forward in embedding AI into clinical workflows, offering both accessibility and affordability in advanced imaging.

Ultrasound+ also delivers measurable benefits for patients and providers. By leveraging AI, radiologists can detect signs of breast and thyroid cancer earlier, reduce unnecessary biopsies and additional imaging, and deliver results with greater accuracy and consistency. The program is reimbursement-eligible, ensuring that patients across SimonMed’s network can access AI-enhanced imaging without additional barriers.

Dr. John Simon, CEO and Founder of SimonMed Imaging, emphasized the importance of the innovation, stating that offering Ultrasound+ at every SimonMed location ensures that all patients undergoing breast or thyroid ultrasounds benefit from AI-driven insights. This technology not only supports earlier cancer detection but also helps minimize unnecessary procedures, ultimately improving outcomes and peace of mind for patients nationwide.